A high impact study led by Daniel Spratt, M.D., Vincent K. Smith Chair in Radiation Oncology at University Hospitals Seidman Cancer Center demonstrates the safety and efficacy of a novel oral hormone therapy, relugolix, in conjunction with radiation therapy for treating men with localized and advanced prostate cancer.
Senate bill would permanently extend Covid-era rules on telehealth addiction treatment
A bipartisan group of senators this week introduced a bill that would permanently allow health providers to prescribe buprenorphine, a common medication used to treat
November 2, 2023